Proceedings of the Fifty-Eighth Annual Meeting of the American Society for Clinical Investigation, Inc., Held in Atlantic City, N.J., May 2, 1966: Abstracts

Total Page:16

File Type:pdf, Size:1020Kb

Proceedings of the Fifty-Eighth Annual Meeting of the American Society for Clinical Investigation, Inc., Held in Atlantic City, N.J., May 2, 1966: Abstracts Proceedings of the Fifty-Eighth Annual Meeting of the American Society for Clinical Investigation, Inc., Held in Atlantic City, N.J., May 2, 1966: Abstracts J Clin Invest. 1966;45(6):980-1037. https://doi.org/10.1172/JCI105414. Research Article Find the latest version: https://jci.me/105414/pdf ABSTRACTS Comparison of Effects of Alpha Adrenergic Blockade luminescence. Inhibition of ATPase activities by ouabain, on Resistance and Capacitance Vessels. FRANCOIS parachloromercuribenzoate (PCMB), and parachloro- M. ABBOUD * AND JOHN W. ECKSTEIN,* Iowa City, mercuribenzenesulfonate (PCMBS) was studied. ¶1 Mem- Iowa. brane ATPase of osmotically prepared platelet "ghosts" A foreleg of each of 20 dogs was perfused with blood is composed of Na+-K+-Mg++-dependent ATPase (15 to at a constant rate through the brachial artery. The 30%) and Mg++-activated ATPase (60 to 85%o). Ouabain nerves of the brachial plexus were transected, and an (10' M), which inhibits the Na+-K--dependent ATPase electrode was applied to their distal ends. Pressures were activity and produces a resultant loss of cellular K+, gain recorded simultaneously from the brachial artery and of Na+, and cell swelling, does not inhibit either ADP cephalic vein and from a small artery and small vein in aggregation or clot retraction. ¶f PCMB, an organic the paw. Pressor responses to injections of nor- mercurial compound that diffuses into cells, totally inacti- epinephrine (1, 2, and 4 /.tg) into the brachial artery and vates both ATPase activities in the ghost preparations to nerve stimulation (3, 6, and 12 cps) were measured and in the intact platelet. PCMBS, a highly polar, poorly before and after intra-arterial administration of 0.25 mg diffusible agent, also inhibits platelet membrane ATPase of phenoxybenzamine; measurements were repeated after activities as evidenced by a 35% cell swelling and the a second dose of 0.5 mg. Increases in total foreleg vascu- loss of up to 50% of the K+ content, but does not inhibit nor- clot retraction by the intact platelet. Both mercurials lar resistance that occurred in response to both 11 epinephrine and nerve stimulation were reduced moderately inhibited ADP aggregation. These observations indicate by phenoxybenzamine, but increases in venous resistance the existence of at least two distinct ATPase activities in were blocked completely. 11 Forearm blood flow (FBF) the human platelet. The Nae-Kt-dependent activity and forearm venous volume at a transmural pressure of necessary for maintaining cation content and cell volume 30 mm Hg (VVw0) were measured in 10 normal human resides within the platelet membrane, can be inactivated subjects with a mercury-in-rubber plethysmograph. Ob- by the PCMBS, but is not essential for clot retraction. servations on the responses of these parameters to infusions ATPase activity essential for clot retraction, by contrast, of norepinephrine (0.075 and 0.15 lug per minute) into the can be localized beneath the outer membrane of the intact brachial artery were made before and after intra-arterial platelet and is unaffected by ouabain or PCMBS. The injection of 0.5 mg of phentolamine; observations were demonstration that PCMBS inhibits ADP aggregation repeated after a second dose of 1.0 mg. Since blood but not clot retraction suggests that ADP aggregation pressure was unaltered, flow changes may be interpreted may not be a necessary step in the process of clot as changes in tone of resistance vessels. Changes in VVs0 retraction. represent changes in compliance of veins or capacitance vessels brought about by changes in tone of venous An Extrarenal Mechanism of Tolerance to Acute smooth muscle. Decreases in FBF with norepinephrine Potassium Loads. EDwARD ALEXANDER AND NORMAN were blocked only partially by phentolamine, whereas G. LEVINSKY,* Boston, Mass. decreases in VVw0 were blocked almost completely. 11 In Rats fed high potassium diets for several days usually these experiments the alpha adrenergic blocking agents survive acute potassium loads that are lethal to rats on phenoxybenzamine and phentolamine were more effective regular diets. It is generally assumed that this tolerance in blocking venous resistance and capacitance responses is due to enhanced urinary potassium excretion. To study to norepinephrine and nerve stimulation than they were tolerance, we fed 150-g rats regular rat diet (unadapted) in blocking prevenous responses to the same stimuli. or diet containing 10% KCl (adapted) for 5 days. Food was withheld for 24 hours before experiment. Without Human Platelet ATPase Activities: Relationship of an acute load, plasma K was equal: adapted, 4.2; un- Localization to Function. Louis M. ALEDORT, STAN- adapted, 4.4 mEq per L. Test rats were given KCl, 5 LEY B. TROUP, AND ROBERT I. WEED,* Rochester, N. Y. mEq per kg intraperitoneally; more than 90% of this was This investigation was undertaken to relate the absorbed within 2 hours. In unadapted rats, plasma K Na+-K+-activated ATPase activity of human platelets to was 5.8 + 1.4 mEq per L 1 hour later and 5.0 + 0.5 mEq the platelet ATPase activity known to be essential for per L 2 hours later. In adapted rats, plasma K was clot retraction. The specific consumption of ATP by significantly lower: 5.0 ± 0.9 at 1 hour (p < 0.05) and platelet ATPases was measured by the use of firefly 4.3 ± 0.5 at 2 hours (p <0.001). Urinary K excretion was less in adapted than in unadapted rats: adapted, * ASCI, active member. 274 + 138; unadapted, 404 + 131 at 2 hours (p <0.01). t ASCI, emeritus member. To confirm the nonrenal mechanism suggested by these ¶1 New paragraph. data, we performed studies on rats nephrectomized im- 980 AMERICAN SOCIETY FOR CLINICAL INVESTIGATION 981 mediately before KCl loading. Plasma K was again in Rh antibody/red cell systems was without prozone, lower in adapted rats 1 and 2 hours after loading: was specific for the Gm(a) factor even when tested with adapted, 4.4+± 0.7 and 5.4-+±0.8 mEq per L; unadapted, an anti-Rh coat of broad specificity for rheumatoid 5.6 + 0.8 and 7.4 + 2.1. The differences at both times factors, and was not inhibited by heat-aggregated Gm(a-) were highly significant (p < 0.01). The plasma bicarbon- 'yG-globulin. Chromatography on Sephadex at low pH ate decreased 3 mmoles per L 2 hours after loading in did not reveal hemagglutinating activity of other specifici- both groups. Isolated diaphragms from adapted and un- ties. Waaler-Rose activity was apparently independent adapted rats maintained identical K contents at equal of anti-Gm specificity by inhibition studies. Anti-Gm(a) external K concentrations in Ringer's medium, suggesting activity was removed by treatment with 0.1 M 2-mercap- that there is no intrinsic mechanism for adaptation. These toethanol and could not be inhibited by heat-aggregated experiments demonstrate a very potent nonrenal mecha- Gm (a-) -yG-globulin. This agglutinator was eluted in nism that regulates plasma K in adapted rats. Because late fractions from DEAE cellulose and was found to of rapid lowering of plasma K by this mechanism, renal sediment between the 19 S and 7 S regions in density excretion is actually decreased in adapted rats during the gradient ultracentrifugation. Gm (a) specific agglutinating first 2 hours after acute loading. activity was absorbed by a specific anti--yA-antiserum used in the region of antibody excess. Studies of this Effects of Left Ventricular Failure on the Pulmonary unique serum offer a further confirmation of the antibody Circulation. J. K. ALEXANDER,* H. L. FRED, M. A. concept of human anti-y-globulin activity by its demon- stration a MODELSKI, D. A. GONZALEZ, AND J. A. BURDINE, JR., in third immunoglobulin class (-yA). They Houston, Texas. provide a bridge between rheumatoid and nonrheumatoid anti--y-globulin antibodies and present an example of In 14 patients with clinical and hemodynamic findings defined isospecificity of hemagglutinating activity asso- of left ventricular failure, structural changes in the ciated with classical rheumatoid factors. pulmonary vasculature were identified by means of selec- tive angiography, and pulmonary capillary blood flow was assessed by Elevation Gradient of Lung Density. J. ALTOBELLI, R. lung scanning after injection of 'I macro- S. E. aggregated albumin. Thirteen patients with a high ACKERLEY, KETNER, M. A. TATTERSALL, AND J. L. calculated pulmonary vascular resistance and low cardiac PATTERSON, JR.,+ Richmond, Va. output demonstrated the following angiographic alterations In an earlier study, intrapleural pressure in the anesthe- at the lung bases bilaterally or unilaterally: 1) closer tized dog, held vertical, was found to increase 0.21 cm approximation of segmental vessels consistent with partial H20 for each cm of vertical distance. Mean lung density atelectasis, 2) narrowing and retarded filling of the in the end-tidal position was 0.22 g per ml lung. The segmental arteries and veins, and 3) abrupt attenuation of mechanism for the intrapleural pressure (Ppl) gradient segmental branch vessels. Pulmonary capillary blood is uncertain, but among the possibilities are 1) the lung flow, as indicated by the scanning technique, was rela- behaves as a homogenous fluid, or 2) a vertical gradient tively reduced in the lower lobes of these patients, whereas of lung density exists that affects the Ppl. The present normally flow to these regions is relatively increased. No investigation explored this second possibility. Ten anes- change in the hemodynamic or angiographic findings took thetized (pentobarbital) mongrel dogs were studied after place during inhalation of 100% 02 for 20 minutes. It has 45 minutes in the vertical head-up position, one in the been concluded that with a high level of pulmonary horizontal, and one in the vertical head-down position. vascular resistance and low cardiac output in left ven- Circulation was stopped by electrical fibrillation and the tricular failure, reduction in perfusion as well as in trachea clamped and thorax entered; pulmonary vessels vascular caliber of the lower lobes develops.
Recommended publications
  • Pharmacologyonline 2: 727-753 (2010) Ewsletter Bradu and Rossini
    Pharmacologyonline 2: 727-753 (2010) ewsletter Bradu and Rossini COTRAST AGETS - IODIATED PRODUCTS. SECOD WHO-ITA / ITA-OMS 2010 COTRIBUTIO O AGGREGATE WHO SYSTEM-ORGA CLASS DISORDERS AD/OR CLUSTERIG BASED O REPORTED ADVERSE REACTIOS/EVETS Dan Bradu and Luigi Rossini* Servizio Nazionale Collaborativo WHO-ITA / ITA-OMS, Università Politecnica delle Marche e Progetto di Farmacotossicovigilanza, Azienda Ospedaliera Universitaria Ospedali Riuniti di Ancona, Regione Marche, Italia Summary From the 2010 total basic adverse reactions and events collected as ADRs preferred names in the WHO-Uppsala Drug Monitoring Programme, subdivided in its first two twenty years periods as for the first seven iodinated products diagnostic contrast agents amidotrizoate, iodamide, iotalamate, iodoxamate, ioxaglate, iohexsol and iopamidol, their 30 WHO-system organ class disorders (SOCDs) aggregates had been compared. Their common maximum 97% levels identified six SOCDs only, apt to evaluate the most frequent single ADRs for each class, and their percentual normalization profiles for each product. The WILKS's chi square statistics for the related contingency tables, and Gabriel’s STP procedure applied to the extracted double data sets then produced profile binary clustering, as well as Euclidean confirmatory plots. They finally showed similar objectively evaluated autoclassificative trends of these products, which do not completely correspond to their actual ATC V08A A, B and C subdivision: while amidotrizoate and iotalamate, and respectively iohesol and iopamidol are confirmed to belong to the A and B subgroups, ioxaglate behaves fluctuating within A, B and C, but iodamide looks surprizingly, constantly positioned together with iodoxamate as binary/ternary C associated. In view of the recent work of Campillos et al (Science, 2008) which throws light on the subject, the above discrepancies do not appear anymore unexpected or alarming.
    [Show full text]
  • Detailed Structure and Pathophysiological Roles of the Iga-Albumin Complex in Multiple Myeloma
    International Journal of Molecular Sciences Article Detailed Structure and Pathophysiological Roles of the IgA-Albumin Complex in Multiple Myeloma Yuki Kawata 1, Hisashi Hirano 1, Ren Takahashi 1, Yukari Miyano 1, Ayuko Kimura 1, Natsumi Sato 1, Yukio Morita 2, Hirokazu Kimura 1,* and Kiyotaka Fujita 1 1 Department of Health Sciences, Gunma Paz University Graduate School of Health Sciences, 1-7-1, Tonyamachi, Takasaki-shi, Gunma 370-0006, Japan; [email protected] (Y.K.); [email protected] (H.H.); [email protected] (R.T.); [email protected] (Y.M.); [email protected] (A.K.); [email protected] (N.S.); [email protected] (K.F.) 2 Laboratory of Public Health II, Azabu University School of Veterinary Medicine, 1-17-71, Fuchinobe, Chuo-ku, Sagamihara, Kanagawa 252-5201, Japan; [email protected] * Correspondence: [email protected]; Tel.: +81-27-365-3366; Fax: +81-27-388-0386 Abstract: Immunoglobulin A (IgA)-albumin complexes may be associated with pathophysiology of multiple myeloma, although the etiology is not clear. Detailed structural analyses of these protein– protein complexes may contribute to our understanding of the pathophysiology of this disease. We analyzed the structure of the IgA-albumin complex using various electrophoresis, mass spectrom- etry, and in silico techniques. The data based on the electrophoresis and mass spectrometry showed that IgA in the sera of patients was dimeric, linked via the J chain. Only dimeric IgA can bind to albumin molecules leading to IgA-albumin complexes, although both monomeric and dimeric forms of IgA were present in the sera.
    [Show full text]
  • Decision Summary
    510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY A. 510(k) Number: k081249 B. Purpose for Submission: New analyte, controls, and calibrator C. Measurand: Alpha 2 macroglobulin D. Type of Test: Quantitative, Nephelometric E. Applicant: Dade Behring, Inc. F. Proprietary and Established Names: Dimension Vista System A2mac Flex Reagent Cartridge, Dimension Vista System Protein 1 Calibrator, Dimension Vista System. G. Regulatory Information: Regulation Section Classification Product Code Panel 21 CFR 866.5620, Alpha- Class II Alpha-2-Macroglobulin, 82 Immunology 2-macroglobulin Antigen, Antiserum, (IM) immunological test Control (DEB) system. 21 CFR 862.1660, Quality Class I Multi-Analyte Controls, 75 Clinical control material (assayed All Kinds (Assayed) Chemistry and unassayed). (JJY) (CH) 21 CFR 862.1150, Class II Calibrator, Multi- 75 Clinical Calibrator. Analyte Mixture (JIX) Chemistry (CH) H. Intended Use: 1. Intended use(s): Dimension Vista® System A2MAC Flex® Reagent Cartridge The A2MAC assay is an in vitro diagnostic test for the quantitative measurement of alpha2-macroglobulin in human serum and heparinized and EDTA plasma on the Dimension Vista® Systems. Measurements of a2-macroglobulin aid in the diagnosis of blood clotting or blood lysis disorders. Dimension Vista® Protein 1 Calibrator Dimension Vista® Protein 1 Calibrator is an in vitro diagnostic product for the calibration of the Dimension Vista® System for: α1-Acid Glycoprotein (A1AG), α1-Antitrypsin(A1AT), α2-Macroglobulin (A2MAC), β2-Microglobulin (B2MIC), C3 Complement (C3), C4 Complement (C4), Ceruloplasmin(CER), Haptoglobin (HAPT), Hemopexin (HPX), Homocysteine (HCYS), Immunoglobulin A (IGA), Immunoglobulin E (IGE), Immunoglobulin G (IGG, IGG-C*), Immunoglobulin G Subclass 1, (IGG1), Immunoglobulin G Subclass 2 (IGG2), Immunoglobulin G 1 Subclass 3 (IGG3), Immunoglobulin Subclass 4 (IGG4), Immunoglobulin M (IGM), Prealbumin (PREALB), Retinol Binding Protein (RBP), soluble Transferrin Receptor (sTFR) and Transferring (TRF).
    [Show full text]
  • Evaluation Report Radiocontrast Agents
    Evaluation report Radiocontrast agents Report No. 187 Within the strategy aimed at reducing micro-pollutant inputs originating from ur- ban and industrial waste water, evaluation reports are being drafted for 10 groups of substances targeted at summarizing scientifi c and technical facts and at pointing out gaps of knowledge. Also, the evaluation reports present a variety of possible mea- sures at the source (e.g. registration of substances, limitation of uses) and technical measures in crucial wastewater treatment plants (e.g. introducing a further treatment stage). The “Conclusions” of the evaluation reports list the most effi cient measures to be further investigated into within a holistic ICPR strategy. However, these measures are no recommendations the ICPR addresses to its member states. Measures listed in this chapter will be integrated into a survey report of all measures in order to be able to take into account eventual synergetic effects of measures (effects of measures on different groups of substances) when proceeding with the fi nal evaluation. Based on the fi nal evaluation of all measures the ICPR will determine recommendations for the Member States Imprint Publisher: International Commission for the Protection of the Rhine (ICPR) Kaiserin-Augusta-Anlagen 15, D 56068 Koblenz P.O. box 20 02 53, D 56002 Koblenz Telephone +49-(0)261-94252-0, Fax +49-(0)261-94252-52 Email: [email protected] www.iksr.org ISBN 935324-53-7 © IKSR-CIPR-ICBR 2010 IKSR CIPR ICBR Evaluation report Radiocontrast agents 1. Introduction Radiocontrast agents are used for diagnostic purposes, as they absorb X-rays to a greater extent than human soft tissue and thus visualize these tissues.
    [Show full text]
  • Informe Tecnico Ufurm-Dfau-Digemid/Minsa
    “Año del Buen Servicio al Ciudadano” ” INFORME TECNICO UFURM-DFAU-DIGEMID/MINSA Proceso: Proceso de revisión y actualización de Petitorio Nacional Único de Medicamentos Esenciales (PNUME) Solicitante: Equipo Técnico para el proceso de revisión y actualización del PNUME I. DATOS DE LA SOLICITUD Medicamento solicitado: Ioversol 320 mg Iodo/mL inyectable Indicación específica: Arteriografía cerebral, periférica, visceral y renal utilizando las técnicas convencionales o la técnica por sustracción digital intra-arterial e intravenosa Institución que lo EsSalud solicita: Número de casos anuales: Motivo de la solicitud Criterios fundamentales 1. Medicamento de eficacia y seguridad demostrada para cubrir vacío importante. 2. Igual eficacia y mayor seguridad e igual o menor costo de tratamiento a las alternativas del PNUME Criterios complementarios No reporta Medicamento solicitado: Ácido ioxaglico (como sal de sodio y meglumina) 320 mg Iodo/mL inyectable Indicación específica: Arteriografia cerebral, periferica, visceral y renal en pacientes con alto riesgo cardiovascular; flebografía y urografía intravenosa; TAC craneal y de cuerpo completo Institución que lo EsSalud solicita: Número de casos anuales: Motivo de la solicitud Criterios fundamentales 1. Medicamento de eficacia y seguridad demostrada para cubrir vació importante. 2. Igual eficacia y mayor seguridad e igual o menor costo de tratamiento a las alternativas del PNUME Criterios complementarios No reporta Medicamento solicitado: Iobitridol 300 mg Iodo/mL inyectable Indicación específica: Indicado en la realización de tomografía (TAC) e intervencionismo; estudios urográficos convencionales; la dosis debe adaptarse al examen y a los territorios que se pretende opacificar, asi como al peso y a la función renal del sujeto, especialmente en el niño Institución que lo Hospital Hipólito Unanue solicita: Número de casos anuales: Motivo de la solicitud Criterios fundamentales “Año del Buen Servicio al Ciudadano” ” 1.
    [Show full text]
  • Radiocontrast Agent Diatrizoic Acid Induces Mitophagy and Oxidative Stress Via Calcium Dysregulation
    International Journal of Molecular Sciences Article Radiocontrast Agent Diatrizoic Acid Induces Mitophagy and Oxidative Stress via Calcium Dysregulation Dakota B. Ward, Kathleen C. Brown and Monica A. Valentovic * Department of Biomedical Sciences, Toxicology Research Cluster, Joan C. Edwards School of Medicine, Marshall University, 1 Marshall Drive, Huntington, WV 25755, USA * Correspondence: [email protected]; Tel.: +1-304-696-7332; Fax: +1-304-696-7391 Received: 20 May 2019; Accepted: 18 August 2019; Published: 21 August 2019 Abstract: Contrast-induced acute kidney injury (CI-AKI) is the third most common cause of hospital associated kidney damage. Potential mechanisms of CI-AKI may involve diminished renal hemodynamics, inflammatory responses, and direct cytotoxicity. The hypothesis for this study is that diatrizoic acid (DA) induces direct cytotoxicity to human proximal tubule (HK-2) cells via calcium dysregulation, mitochondrial dysfunction, and oxidative stress. HK-2 cells were exposed to 0–30 mg I/mL DA or vehicle for 2–24 h. Conversion of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and trypan blue exclusion indicated a decrease in mitochondrial and cell viability within 2 and 24 h, respectively. Mitochondrial dysfunction was apparent within 8 h post exposure to 15 mg I/mL DA as shown by Seahorse XF cell mito and Glycolysis Stress tests. Mitophagy was increased at 8 h by 15 mg I/mL DA as confirmed by elevated LC3BII/I expression ratio. HK-2 cells pretreated with calcium level modulators BAPTA-AM, EGTA, or 2-aminophenyl borinate abrogated DA-induced mitochondrial damage. DA increased oxidative stress biomarkers of protein carbonylation and 4-hydroxynonenol (4HNE) adduct formation.
    [Show full text]
  • Plasma Proteins & Immunoglobulins Peter J
    CHAPTER 52 Plasma Proteins & Immunoglobulins Peter J. Kennelly, PhD, Robert K. Murray, MD, PhD, Molly Jacob, MBBS, MD, PhD & Joe Varghese, MBBS, MD 1529 BIOMEDICAL IMPORTANCE The proteins that circulate in blood plasma play important roles in human physiology. Albumins facilitate the transit of fatty acids, steroid hormones, and other ligands between tissues, while transferrin aids the uptake and distribution of iron. Circulating fibrinogen serves as a readily mobilized building block of the fibrin mesh that provides the foundation of the clots used to seal injured vessels. Formation of these clots is triggered by a cascade of latent proteases, or zymogens, called blood coagulation factors. Plasma also contains several proteins that function as inhibitors of proteolytic enzymes. Antithrombin helps confine the formation of clots to the vicinity of a wound, while α1-antiproteinase and α2-macroglobulin shield healthy tissues from the proteases that destroy invading pathogens and remove dead or defective cells. Circulating immunoglobulins called antibodies form the front line of the body’s immune system. Perturbances in the production of plasma proteins can have serious health consequences. Deficiencies in key components of the blood clotting cascade can result in excessive bruising and bleeding (hemophilia). Persons lacking plasma ceruloplasmin, the body’s primary carrier of copper, are subject to hepatolenticular degeneration (Wilson disease), while emphysema is associated with a genetic deficiency in the production of circulating α1-antiproteinase. More than one in every 30 residents of North America suffer from an autoimmune disorder, such as type 1 diabetes, asthma, and rheumatoid arthritis, resulting from the production of aberrant immunoglobulins (Table 52–1).
    [Show full text]
  • DISEASE of the MONTH J Am Soc Nephrol 11: 177–182, 2000
    DISEASE OF THE MONTH J Am Soc Nephrol 11: 177–182, 2000 Contrast Nephropathy SEAN W. MURPHY, BRENDAN J. BARRETT, and PATRICK S. PARFREY Division of Nephrology and Clinical Epidemiology Unit, Memorial University of Newfoundland, St. John’s, Newfoundland, Canada. With the increasing use of radiographic contrast media in changes of cell injury and enzymuria after contrast administration diagnostic and interventional procedures, contrast-induced ne- (9). The nature of the contrast, associated ions, concentration, and phropathy (CN) has become an important cause of iatrogenic concomitant hypoxia are all important to the degree of cellular acute renal impairment. In fact, CN is the third leading cause damage, while the osmolality of the solution seems to be of of new acute renal failure in hospitalized patients (1). The secondary importance (8). The injection of contrast induces a pathophysiology and risk factors for this complication are biphasic hemodynamic change in the kidney, with an initial, becoming better understood, but there is still controversy sur- transient increase and then a more prolonged decrease in renal rounding many aspects. The purpose of this article is to review blood flow (2). The mediators of these changes are still unknown. recent developments in the area of CN. Particular emphasis Alterations in the metabolism of prostaglandin, nitric oxide, en- will be placed on means of minimizing the risk or preventing dothelin, or adenosine may play a role. this important problem. Risk Factors and Epidemiology Definition and Clinical Features Mild, transient decreases in GFR occur after contrast admin- Many different definitions of CN appear in the literature, but istration in almost all patient (10).
    [Show full text]
  • Serum Protein Electrophoresis
    6/17/2013 Serum Protein Electrophoresis Karina Rodriguez-Capote MD, PhD, FCACB, Clinical Chemist, DynaLIFEDx 2013 Laboratory Medicine Symposium Objectives • Describe the electrophoresis procedure used to separate serum proteins and to identify a monoclonal protein • Indications for serum protein electrophoresis (SPE) • Describe how immunofixation electrophoresis (IFE) is used to identify the heavy and light chain of a monoclonal protein • Interpretation: common patterns & pitfalls • Describe the diagnostic criteria used to identify patients with monoclonal gammopathy 1 6/17/2013 Electrophoresis: the proteins are separated according to their electrical charges on agarose gel using both the electrophoretic and electroendosmotic forces present in the system. Staining : After the proteins are separated, the plate is placed in a solution to stain the protein bands. The staining intensity is related to protein concentration After dehydration in methanol, the plate background is then made transparent by treatment with a clearing solution. Drying Interpretation Additional testing: IFE, FLC, IGQ Plate Soaking Time..................................20 minutes Electrophoresis Time...............................15 minutes Stain Time................................................6 minutes Destain Time in 5% Acetic Acid.............. 3 times/10 minutes Dehydration Time in Methanol.................2 times/2 minutes Clearing ................................................ 5-10 minutes. Drying .....................................................20 minutes
    [Show full text]
  • Alpha2-Macroglobulin Levels in Disease in Man
    J Clin Pathol: first published as 10.1136/jcp.21.1.27 on 1 January 1968. Downloaded from J. clin. Path. (1968), 21, 27 Alpha2-macroglobulin levels in disease in man JAMES HOUSLEY From the Department of Experimental Pathology, University of Birmingham, Birmingham SYNOPSIS Serum a2-macroglobulin levels were measured in normal subjects and in patients with various diseases by an immunochemical method. The values for normal men were 284 mg./100 ml. (±89 6 mg./100 ml.) and for normal women 350 mg./100 ml. (±94 5 mg./100 ml.). Men with rheumatoid arthritis had normal levels, but the levels in women were depressed. There was no relationship to the concentrations of the acute phase reactive proteins, haptoglobin, and C-reactive protein. In chronic liver disease, the levels in men were significantly higher than normal and were slightly higher than normal in women. A small group of patients with nephrotic syndrome had very high levels. No significant variations from the normal were found in sera from a group of patients with miscellaneous diseases. Experimental studies indicate that serum a2-macro- also been measured in patients with chronic liver globulin binds trypsin (Haverback, Dyce, Bundy, disease, who frequently show quantitative serum Wirtschafter, and Edmondson, 1962; Mehl, protein abnormalities (Sherlock, 1963), in a small O'Connell, and DeGroot, 1964), plasmin (Schultze, number of nephrotic patients, in whom high levels Heimburger, Heide, Haupt, Storiko, and Schwick, have been reported (Schultze and Schwick, 1959; 1963), and thrombin (Lanchantin, Plesser, Fried- Steines and Mehl, 1966), and in a group of patients mann, and Hart, 1966), and may also transport with miscellaneous diseases.
    [Show full text]
  • Serum & Urine Protein Electrophoresis
    Serum & urine protein electrophoresis Take a test Normal or abnormal? Definitions Electrophoresis is a method of separating proteins based on their physical properties. Serum is placed on a specific medium, and a charge is applied. The net charge (positive or negative) and the size and shape of the protein commonly are used in differentiating various serum proteins. Definitions Several subsets of serum protein electrophoresis are available. The proteins are stained, and their densities are calculated electronically to provide graphical data on the absolute and relative amounts of the various proteins. Further separation of protein subtypes is achieved by staining with an immunologically active agent, which results in immunofluorescence and immunofixation. Components of Serum Protein Electrophoresis The pattern of serum protein electrophoresis results depends on the fractions of two major types of protein: albumin and globulins. Components of Serum Protein Electrophoresis Albumin, the major protein component of serum, is produced by the liver under normal physiologic conditions. Globulins comprise a much smaller fraction of the total serum protein content. The subsets of these proteins and their relative quantity are the primary focus of the interpretation of serum protein electrophoresis. Components of Serum Protein Electrophoresis Albumin, the largest peak, lies closest to the positive electrode. The next five components (globulins) are labeled alpha1, alpha2, beta1, beta2, and gamma. The peaks for these components lie toward the negative electrode, with the gamma peak being closest to that electrode. serum protein electrophoresis normal pattern ALBUMIN The albumin band represents the largest protein component of human serum. The albumin level is decreased under circumstances in which there is less production of the protein by the liver or in which there is increased loss or degradation of this protein.
    [Show full text]
  • Structural Characterization of Bacterial Defense Complex Marko Nedeljković
    Structural characterization of bacterial defense complex Marko Nedeljković To cite this version: Marko Nedeljković. Structural characterization of bacterial defense complex. Biomolecules [q-bio.BM]. Université Grenoble Alpes, 2017. English. NNT : 2017GREAV067. tel-03085778 HAL Id: tel-03085778 https://tel.archives-ouvertes.fr/tel-03085778 Submitted on 22 Dec 2020 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. THÈSE Pour obtenir le grade de DOCTEUR DE LA COMMUNAUTE UNIVERSITE GRENOBLE ALPES Spécialité : Biologie Structurale et Nanobiologie Arrêté ministériel : 25 mai 2016 Présentée par Marko NEDELJKOVIĆ Thèse dirigée par Andréa DESSEN préparée au sein du Laboratoire Institut de Biologie Structurale dans l'École Doctorale Chimie et Sciences du Vivant Caractérisation structurale d'un complexe de défense bactérienne Structural characterization of a bacterial defense complex Thèse soutenue publiquement le 21 décembre 2017, devant le jury composé de : Monsieur Herman VAN TILBEURGH Professeur, Université Paris Sud, Rapporteur Monsieur Laurent TERRADOT Directeur de Recherche, Institut de Biologie et Chimie des Protéines, Rapporteur Monsieur Patrice GOUET Professeur, Université Lyon 1, Président Madame Montserrat SOLER-LOPEZ Chargé de Recherche, European Synchrotron Radiation Facility, Examinateur Madame Andréa DESSEN Directeur de Recherche, Institut de Biologie Structurale , Directeur de These 2 Contents ABBREVIATIONS ..............................................................................................................................
    [Show full text]